Allianz Asset Management
INDV icon

Allianz Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Allianz Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
12,310
+1,010
+9% +$36.6K ﹤0.01% 2012
2026
Q1 		$363K Buy
+11,300
New +$373K ﹤0.01% 1879
2025
Q2 		– Sell
-185,000
Closed -$1.73M – 2151
2025
Q1 		$1.73M Sell
185,000
-37,811
-17% -$398K ﹤0.01% 1526
2024
Q4 		$2.86M Sell
222,811
-189,647
-46% -$1.95M ﹤0.01% 1284
2024
Q3 		$4.07M Buy
412,458
+22,648
+6% +$265K 0.01% 1139
2024
Q2 		$6.11M Buy
+389,810
New +$7.04M 0.01% 870

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allianz Asset Management's INDV Position: Q2 2026 in Review

Allianz Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 8.9% in Q2 2026, buying an estimated $36.6K and bringing the position to 12,310 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Allianz Asset Management first reported a position in INDV in Q2 2024 and has held it in 6 quarters since. The position peaked at $6.11M in Q2 2024. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Allianz Asset Management held 12,310 shares of Indivior Pharmaceuticals worth $409K as of Q2 2026.
  • Allianz Asset Management bought 1,010 Indivior Pharmaceuticals shares in Q2 2026, an estimated $36.6K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #2012 holding.
  • Allianz Asset Management first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Allianz Asset Management's Indivior Pharmaceuticals position peaked at $6.11M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.